Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
Clinical trial NCT03010436 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03010436
- Sponsor
- National Jewish Health
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-15
- Primary completion
- 2019-07-25
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.